Trials / Unknown
UnknownNCT04327349
Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Mazandaran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Coronavirus disease 2019 (COVID-19) was recognized as a pandemic on March 11, 2020 by the World Health Organization. The virus that causes COVID-19 (SARS-CoV-2) is easily transmitted through person to person and there is still no specific approach against the disease and mortality rate in severe cases is also significant. Therefore, finding effective treatment for the mortality of these patients is very important. In this study the investigators aim to determine the effect of Convalescent Plasma on COVID-19 patients Outcome through a Clinical Trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Convalescent Plasma | Intervention to evaluate convalescent plasma transfer to COVID-19 patients admitted to ICU |
Timeline
- Start date
- 2020-03-28
- Primary completion
- 2020-05-20
- Completion
- 2020-09-30
- First posted
- 2020-03-31
- Last updated
- 2020-03-31
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT04327349. Inclusion in this directory is not an endorsement.